Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHD | ROKU |
|---|---|---|
| Price | $94.31 | $150.75 |
| Change today | ▲ 0.10% | ▼ 1.00% |
| Market cap | $22.37B | $22.39B |
| Return, 3 months | -2.7% | +7.3% |
| Return, year to date | +13.5% | +39.0% |
| Return, 1 year | +8.7% | +45.6% |
| P/E (TTM) | 30.2 | 63.9 |
| P/B | 5.1 | 7.9 |
| P/E percentile vs own 5y | 28th | 72nd |
| Dividend yield | 1.28% | – |
| Revenue growth (YoY, latest qtr) | +1.6% | +21.9% |
| Net profit growth (YoY) | +6.2% | +1,463.5% |
| Gross margin | 45.6% | 45.5% |
| Operating margin | 17.5% | 5.2% |
| Net margin | 12.0% | 6.8% |
| Return on equity | 17.0% | 13.1% |
| Analyst target vs. price | +13.9% | +7.9% |
| Analyst buy share | 55% | 11% |
| RSI (14) | 38 | 44 |
| 30-day volatility | 17.7% | 13.0% |
| Max drawdown, 1 year | -13.8% | -27.7% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
